Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
BMC Cardiovasc Disord ; 24(1): 387, 2024 Jul 27.
Article in English | MEDLINE | ID: mdl-39068384

ABSTRACT

BACKGROUND AND PURPOSE: Cerebrovascular events during thrombolysis in cardiac arrest (CA) caused by pulmonary embolism (PE) is a life-threatening condition. However, the balance between cerebrovascular events and thrombolytic therapy in PE-induced CA remains a great challenge. METHODS: In this study, we reported three unique cases regarding main concerns surrounding cerebrovascular events in thrombolytic therapy in PE-induced CA. RESULTS: The patient in the case 1 treated with thrombolysis during CPR and finally discharged neurologically intact. The patient in the case 2 received delayed thrombolysis and died eventually. The patient in the case 3 was contraindicated to thrombolysis due to the complication of subarachioid hemorrahage and died within days. CONCLUSIONS: Our case series highlights three proposed approaches to consider before administering thrombolysis as a treatment option in PE-induced CA patients: (1) prolonging the resuscitation, (2) administering thrombolysis promptly, and (3) ruling out cerebrovascular events.


Subject(s)
Fibrinolytic Agents , Heart Arrest , Pulmonary Embolism , Thrombolytic Therapy , Humans , Pulmonary Embolism/drug therapy , Pulmonary Embolism/diagnostic imaging , Pulmonary Embolism/diagnosis , Pulmonary Embolism/etiology , Thrombolytic Therapy/adverse effects , Male , Heart Arrest/diagnosis , Heart Arrest/etiology , Heart Arrest/therapy , Fibrinolytic Agents/adverse effects , Fibrinolytic Agents/administration & dosage , Treatment Outcome , Middle Aged , Aged , Fatal Outcome , Female , Cardiopulmonary Resuscitation , Risk Factors , Time-to-Treatment , Time Factors , Clinical Decision-Making
SELECTION OF CITATIONS
SEARCH DETAIL